Retraction: miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2 (Int. J. Mol. Sci. (2014), 15, (423–437), 10.3390/ijms15010423);miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2

International Journal of Molecular Sciences

Volumn 15, Issue 1, 2014, Pages 423-437

  Yang, Chenglin ^a   Hou, Chunying ^a   Zhang, Hepeng ^a   Wang, Dewei ^a   Ma, Yan ^a   Zhang, Yunqi ^a   Xu, Xiaoyan ^a   Bi, Zhenggang ^a   Geng, Shuo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

miR 126; Osteosarcoma; Sex determining region Y box 2; Tumor suppressor

Indexed keywords

MICRORNA 126; TRANSCRIPTION FACTOR SOX2; 3' UNTRANSLATED REGION; ANTISENSE OLIGONUCLEOTIDE; MICRORNA; MIRN126 MICRORNA, HUMAN; TRANSCRIPTION FACTOR SOX;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; OSTEOSARCOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; 3' UNTRANSLATED REGION; BONE TUMOR; CELL MOTION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; APOPTOSIS; BASE SEQUENCE; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; OSTEOSARCOMA; SEQUENCE ALIGNMENT; SOXB1 TRANSCRIPTION FACTORS;

EID: 84891645275     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19113541     Document Type: Erratum

References (34)

1. Rabinowicz, R.; Barchana, M.; Liphshiz, I.; Futerman, B.; Linn, S.; Weyl-Ben-Arush, M. Cancer incidence and survival among children and adolescents in israel during the years 1998 to 2007. J. Pediatr. Hematol. Oncol. 2012, 34, 421-429.
2. Carroll, K.L.; Yandow, S.M.; Ward, K.; Carey, J.C. Clinical correlation to genetic variations of hereditary multiple exostosis. J. Pediatr. Orthoped. 1999, 19, 785-791.
3. Pierz, K.A.; Womer, R.B.; Dormans, J.P. Pediatric bone tumors: Osteosarcoma ewing's sarcoma, and chondrosarcoma associated with multiple hereditary osteochondromatosis. J. Pediatr. Orthoped. 2001, 21, 412-418.
4. Bartel, D.P. Micrornas: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297.
5. Kong, Y.W.; Ferland-McCollough, D.; Jackson, T.J.; Bushell, M. Micrornas in cancer management. Lancet Oncol. 2012, 13, e249-e258.
6. Gurtan, A.M.; Sharp, P.A. The role of mirnas in regulating gene expression networks. J. Mol. Biol. 2013, 425, 3582-3600.
7. Miao, J.; Wu, S.; Peng, Z.; Tania, M.; Zhang, C. Micrornas in osteosarcoma: Diagnostic and therapeutic aspects. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 2013, 34, 2093-2098.
8. Wang, Z.; Cai, H.; Lin, L.; Tang, M.; Cai, H. Upregulated expression of microrna-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Pediatr. Blood Cancer 2013, doi:10.1002/pbc. 24763.
9. Song, L.; Yang, J.; Duan, P.; Xu, J.; Luo, X.; Luo, F.; Zhang, Z.; Hou, T.; Liu, B.; Zhou, Q. Microrna-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting lpaatbeta. Arch. Biochem. Biophys. 2013, 535, 128-135.
10. Namlos, H.M.; Meza-Zepeda, L.A.; Baroy, T.; Ostensen, I.H.; Kresse, S.H.; Kuijjer, M.L.; Serra, M.; Burger, H.; Cleton-Jansen, A.M.; Myklebost, O. Modulation of the osteosarcoma expression phenotype by micrornas. PLoS One 2012, 7, e48086.
11. Meister, J.; Schmidt, M.H. miR-126 and miR-126*: New players in cancer. Sci. World J. 2010, 10, 2090-2100.
12. Nikolic, I.; Plate, K.H.; Schmidt, M.H. Egfl7 meets mirna-126: An angiogenesis alliance. J. Angiogenes. Res. 2010, 2, 9.
13. Wang, S.; Aurora, A.B.; Johnson, B.A.; Qi, X.; McAnally, J.; Hill, J.A.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. The endothelial-specific microrna miR-126 governs vascular integrity and angiogenesis. Dev. Cell 2008, 15, 261-271.
14. Harris, T.A.; Yamakuchi, M.; Ferlito, M.; Mendell, J.T.; Lowenstein, C.J. Microrna-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. USA 2008, 105, 1516-1521.
15. Liu, B.; Peng, X.C.; Zheng, X.L.; Wang, J.; Qin, Y.W. miR-126 restoration down-regulate vegf and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 2009, 66, 169-175.
16. Berta, P.; Hawkins, J.R.; Sinclair, A.H.; Taylor, A.; Griffiths, B.L.; Goodfellow, P.N.; Fellous, M. Genetic evidence equating sry and the testis-determining factor. Nature 1990, 348, 448-450.
17. Collignon, J.; Sockanathan, S.; Hacker, A.; Cohen-Tannoudji, M.; Norris, D.; Rastan, S.; Stevanovic, M.; Goodfellow, P.N.; Lovell-Badge, R. A comparison of the properties of sox-3 with sry and two related genes, sox-1 and sox-2. Development 1996, 122, 509-520.
18. Sarkar, A.; Hochedlinger, K. The sox family of transcription factors: Versatile regulators of stem and progenitor cell fate. Cell Stem Cell 2013, 12, 15-30.
19. Otsubo, T.; Akiyama, Y.; Hashimoto, Y.; Shimada, S.; Goto, K.; Yuasa, Y. Microrna-126 inhibits sox2 expression and contributes to gastric carcinogenesis. PLoS One 2011, 6, e16617.
20. Leonardo, T.R.; Schultheisz, H.L.; Loring, J.F.; Laurent, L.C. The functions of micrornas in pluripotency and reprogramming. Nat. Cell Biol. 2012, 14, 1114-1121.
21. Xu, J.Q.; Liu, P.; Si, M.J.; Ding, X.Y. Microrna-126 inhibits osteosarcoma cells proliferation by targeting sirt1. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 2013, doi:10.1007/s13277-013-0974-x.
22. Yuan, H.; Corbi, N.; Basilico, C.; Dailey, L. Developmental-specific activity of the fgf-4 enhancer requires the synergistic action of sox2 and oct-3. Genes Dev. 1995, 9, 2635-2645.
23. Bylund, M.; Andersson, E.; Novitch, B.G.; Muhr, J. Vertebrate neurogenesis is counteracted by sox1-3 activity. Nat. Neurosci. 2003, 6, 1162-1168.
24. Wegner, M. From head to toes: The multiple facets of sox proteins. Nucleic Acids Res. 1999, 27, 1409-1420.
25. Hussenet, T.; Dali, S.; Exinger, J.; Monga, B.; Jost, B.; Dembele, D.; Martinet, N.; Thibault, C.; Huelsken, J.; Brambilla, E.; et al. Sox2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One 2010, 5, e8960.
26. Saigusa, S.; Tanaka, K.; Toiyama, Y.; Yokoe, T.; Okugawa, Y.; Ioue, Y.; Miki, C.; Kusunoki, M. Correlation of cd133, oct4, and sox2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann. Surg. Oncol. 2009, 16, 3488-3498.
27. Jia, X.; Li, X.; Xu, Y.; Zhang, S.; Mou, W.; Liu, Y.; Liu, Y.; Lv, D.; Liu, C.H.; Tan, X.; et al. Sox2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. J. Mol. Cell Biol. 2011, 3, 230-238.
28. Sun, C.; Sun, L.; Li, Y.; Kang, X.; Zhang, S.; Liu, Y. Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating slug. Med. Oncol. 2013, 30, 503.
29. Lin, F.; Lin, P.; Zhao, D.; Chen, Y.; Xiao, L.; Qin, W.; Li, D.; Chen, H.; Zhao, B.; Zou, H.; et al. Sox2 targets cycline, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis. Cell Prolifer. 2012, 45, 207-216.
30. Basu-Roy, U.; Seo, E.; Ramanathapuram, L.; Rapp, T.B.; Perry, J.A.; Orkin, S.H.; Mansukhani, A.; Basilico, C. Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene 2012, 31, 2270-2282.
31. Guo, X.; Liu, Q.; Wang, G.; Zhu, S.; Gao, L.; Hong, W.; Chen, Y.; Wu, M.; Liu, H.; Jiang, C.; et al. Microrna-29b is a novel mediator of sox2 function in the regulation of somatic cell reprogramming. Cell Res. 2013, 23, 142-156.
32. Deng, Z.; Du, W.W.; Fang, L.; Shan, S.W.; Qian, J.; Lin, J.; Qian, W.; Ma, J.; Rutnam, Z.J.; Yang, B.B. The intermediate filament vimentin mediates microrna miR-378 function in cellular self-renewal by regulating the expression of the sox2 transcription factor. J. Biol. Chem. 2013, 288, 319-331.
33. Li, J.; Du, L.; Yang, Y.; Wang, C.; Liu, H.; Wang, L.; Zhang, X.; Li, W.; Zheng, G.; Dong, Z. miR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting sox2. Cancer Lett. 2013, 329, 84-90.
34. Zhang, Y.; Eades, G.; Yao, Y.; Li, Q.; Zhou, Q. Estrogen receptor alpha signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor sox2. J. Biol. Chem. 2012, 287, 41514-41522.